• YouTube
    • Facebook

    GRESP GRESP

    • Início
    • Sobre Nós
      • Comissão Coordenadora
      • Objetivos
      • Grupos de Trabalho
        • Doença Pulmonar Obstrutiva Crónica
        • Asma e Rinite
        • Apneia do Sono e Cuidados Respiratórios Domiciliários
        • Doenças Infeciosas
        • Doenças Oncológicas Respiratórias
        • Reabilitação Respiratória
        • Tabagismo
        • Dispositivos inalatórios
        • Formação e Investigação
        • Prevenção
        • Comunicacao e Digital
        • Avaliação Funcional Respiratória
      • Patrocínio Científico
      • Novas Inscrições
    • Eventos
    • Recursos
      • Minuto GRESP
      • Folhetos / Guias práticos
      • Vídeos
        • Dispositivos Inalatórios e Técnica Inalatória
        • Reabilitação Respiratória
      • Testes e questionários
        • ADO Index
        • BODE e BODEx
        • DOSE
        • Measurement of Health-Related Quality of Life & Asthma Control
      • Recursos por tema
        • Asma e Rinite
        • DPOC
        • Avaliação funcional respiratória
        • SAOS e CRD
        • Dispositivos inalatórios e técnica inalatória
        • Doenças respiratórias infeciosas
        • Tabagismo
        • Vacinação
      • Leituras / Discussão
    • Galeria
    • Contatos
    • Links Úteis

    A Não Perder

    • COPD management costs according to the frequency of COPD exacerbations in UK primary care
    • Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study
    • Tobacco 21 — An Idea Whose Time Has Come
    • Mobile phone-based asthma self-management aid for adolescents (mASMAA): a feasibility study
    • The Renormalization of Smoking? E-Cigarettes and the Tobacco “Endgame”
    • Global Effects of Smoking, of Quitting, and of Taxing Tobacco
    • Current and Novel Bronchodilators in Respiratory Disease
    • The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects.
    • [ BROKEN LINK ] Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement Asthma: standards of care
    • Prevalence and classification of rhinitis in the elderly: a nationwide survey in Portugal.
    • [ BROKEN LINK ] A 1-year follow-up study exploring the associations between perception of illness and health-related quality of life in persons with chronic obstructive pulmonary disease
    • Effectiveness of spirometry as a motivational tool for smoking cessation: a clinical trial, the ESPIMOAT study
    • Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk Patients
    • [ BROKEN LINK ] PSI, CURB-65, SMART-COP or SCAP? And the winner is… SMART DOCTORS
    • Duration of symptoms of respiratory tract infections in children: systematic review
    • Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease
    • Use of a care bundle in the emergency department for acute exacerbations of chronic obstructive pulmonary disease: a feasibility study
    • Update on the Potential Role of Statins in Chronic Obstructive Pulmonary Disease and its Co-morbidities
    • Ashgabat Declaration on noncommunicable diseases
    • Respiratory mechanics and ventilatory control in overlap syndrome and obesity hypoventilation
    • Impact of night-time symptoms in COPD: a real-world study in five European countries
    • Noninvasive positive pressure ventilation in subjects with stable COPD: a randomized trial
    • The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data
    • EC Approves Fluticasone Furoate/Vilanterol for Asthma, COPD
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    • 25
    • 26

    Gresp no Facebook

    Siga-nos no Facebook e fique a par de todas as novidades na área das doenças respiratórias.

    APMGFIPCRG

    Contatos

    Mail: gresp@apmgf.pt

    • Novas inscrições
    • Patrocínio científico

    Associação Portuguesa de Medicina Geral e Familiar

    Av. da República, 97 – 1.º
    1050-190 Lisboa – Portugal
    Telf. +351 217 615 250
    Fax: +351 217 933 145

    © 2025 GRESP. Todos os direitos reservados